The first evidence to show the relevance of DNA methylation to AMD is the abnormal methylation of CLU and gene encoding clusterin, which contains CpG islands in its promoter region and which may have anti-inflammatory and anti-angiogenic functions. Here, CLU is linked to age-related macular degeneration.